Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Howe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of the Acoustical Society of America|December 2, 2010
Comments on single-mass models of vocal fold vibrationRichard S McGowan, Michael S Howe
The Journal of the Acoustical Society of America|April 17, 2012
Source-tract interaction with prescribed vocal fold motionRichard S McGowan, Michael S Howe
The Journal of the Acoustical Society of America|March 25, 2010
Influence of the ventricular folds on a voice source with specified vocal fold motionRichard S McGowan, Michael S Howe
Plos One|June 7, 2019
The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNAPeter J G Cussell, Michael S Howe, Thomas A Illingworth, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of the Acoustical Society of America|December 2, 2010
Comments on single-mass models of vocal fold vibrationRichard S McGowan, Michael S Howe
The Journal of the Acoustical Society of America|April 17, 2012
Source-tract interaction with prescribed vocal fold motionRichard S McGowan, Michael S Howe
The Journal of the Acoustical Society of America|March 25, 2010
Influence of the ventricular folds on a voice source with specified vocal fold motionRichard S McGowan, Michael S Howe
Plos One|June 7, 2019
The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNAPeter J G Cussell, Michael S Howe, Thomas A Illingworth, et al.
Pageof 1